-
BON Natural Life launches AI-driven drug research and development unit
-
BON signs $22 million distribution deal for weight loss products
-
BON Natural Life regains Nasdaq compliance
-
Bon Natural Life (BON) Announces Breakthrough Order for $16M Gut-Health Products
-
Bon Natural Life (BON) Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co
-
Bon Natural Life (BON) Announces $1M Share Buyback
-
Bon Natural Life (BON) Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement
-
Bon Natural Life (BON) Announces Effectiveness of 1:25 Reverse Share Split
-
Bon Natural Life (BON) launches sleep health product series
-
Bon Natural Life (BON) receives Nasdaq minimum bid notice
-
Bon Natural Life (BON) Announces Apple Polyphenol Commercial Order Signed
-
Bon Natural Life (BON) Announces Breakthrough in the Bio-manufacturing Technology of Tea Pigments
-
Bon Natural Life (BON) Prices 8.33M Share Offering at $2.16/sh

